Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Suicide Clinical Trials

A listing of Suicide medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (19) clinical trials

Wearable Suicidal Early Warning System for Adolescents

This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department with acute suicidality. The plan is to monitor basic physiologic parameters to assess for trends associated with suicidality noninvasively in an objective manner beyond subjective questionnaires currently available. Patients will be enrolled if presenting ...

Phase N/A

Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters

Every patient who is discharged after a suicidal gesture will be proposed to enter the program. He will be handed a "green card" with a toll-free and unique phone number and an information letter which explains the program and his rights as a patient. Phone calls Calling team is composed ...

Phase N/A

Long-term Prognosis of Cluster Headache: a Retrospective Cohort Study

Cluster headache is a syndrome characterized by disabling headache and accompanying autonomic symptoms. Despite cluster headache is called "suicide headache", its natural history has not been well investigated. The investigators aimed to investigate its disease course, overall prognosis, and treatment pattern in retrospective cohort.

Phase N/A

Protective Factors Against Elderly Suicide

France has a suicide rate (16.2 per 100 000 inhabitants) well above the European average rate (10.2 per 100 000 inhabitants). The Poitou-Charentes region is in a situation of excess mortality by suicide compared to France (+ 25%). While the ratio of suicide attempts per suicide is about 200/1 before ...

Phase N/A

Pain Reward Attention and Neurocircuitry: Biomarkers of Suicidality

The ultimate aim of this study is to identify a biomarker of suicide risk in MDD by measuring the "hedonic spectrum" (pain and reward responsivity), attention and its associated brain structures using brain scans (fMRI and DTI), as well as the stability of markers over time.

Phase N/A

A Study Examining Adolescents With Non-Suicidal Self-Injury

This study is designed to study brain development in 12-14 year old females with a history of NSSI. Assessments will take place over the course of three years, with three visits per year a total of nine visits. The first visit will take place at the Ambulatory Research Center (ARC) ...

Phase N/A

Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 (week 0), visit ...

Phase N/A

Evaluation of Cognitive Function in a Suicidal Crisis

The aftermath of suicide is devastating, being the cause of 800 000 deaths every year worldwide. In France, suicide still causes about 10 000 deaths per year and the number of suicide attempts (SA) is estimated between 170 000 and 200 000 per year (InVS). It is often thought that ...

Phase N/A

Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical Setting

Physicians and nurses working in non-mental health settings require tools to guide them in recognizing patients at risk. While screening children and adolescents is emerging as a priority of the Joint Commission, there are currently no suicide screening instruments designed specifically for assessing suicide risk in a pediatric inpatient medical ...

Phase N/A

Assessing Suicide Risk in Adolescents With Developmental Delays

Objective Currently, no gold standard is available for evaluating suicidal thoughts and behaviors in individuals with developmental delay or intellectual disabilities (DD/ID). Moreover, youth with DD are often excluded from instrument validation studies. Therefore, there is a paucity of sufficiently adapted and validated clinical suicide risk assessments for use with ...

Phase N/A